NRG-1 talks back to neurons by LeBrasseur, Nicole
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
In This Issue 1007
 
T
 
EXT
 
 B
 
Y
 
 N
 
ICOLE
 
 L
 
E
 
B
 
RASSEUR
LEBRASN
 
@
 
ROCKEFELLER
 
.
 
EDU
 
NRG-1 talks back to neurons
 
n page 1133, Bao et al. demonstrate that a neuronal 
growth factor signals to neighboring cells while also 
communicating back to the nucleus of its own cell. This 
two-way signaling is necessary to maintain neuronal survival.
In the for-
ward direc-
tion, either 
a soluble or 
membrane-
bound form 
of the Nrg-1 
growth fac-
tor activates 
erbB receptor tyrosine kinases on a variety of adjacent cells. 
The Nrg-1/erbB partnership is well known to control responses 
in the erbB-expressing cells, such as epithelial cell motility and 
proliferation, through MAP kinase pathways. Now, the target 
cells are shown to talk back to neurons that express membrane-
bound Nrg-1 via the same erbB–Nrg-1 complex.
Bao et al. show that treatment with soluble erbB protects 
Nrg-1–expressing neurons from cell death in vitro. The 
protective activity appears to stem from Nrg-1’s ability to 
regulate transcription of apoptotic genes, including BAK 
and RIP, whose expression levels were repressed by treatment 
with erbB. Membrane-bound Nrg-1 was cleaved by a 
 
 
 
-secretase–like activity in response to erbB treatment, thus 
releasing the Nrg-1 intracellular domain, which moved to 
the nucleus. Although Nrg-1 has not been shown to bind 
to DNA, the authors demonstrate that it does has trans-
activating activity on a reporter construct, and preliminary 
evidence indicates it may interact with zinc finger–containing 
transcription factors.
 
 
 
 
O
The intracellular domain of Nrg-1 (red) moves to 
the nucleus (blue) upon erbB treatment (right).
 
Golgi united are also divided
 
olgi bodies do not need to disassemble to divide, according 
to results from Uchiyama et al. on page 1067. 
In mammalian cells, the Golgi apparatus disassembles into 
vesicles and short tubules before mitosis. Golgi breakdown 
requires that two membrane fusion pathways necessary for 
Golgi reassembly after mitosis be temporarily inhibited. For 
one, the NSF pathway, this inhibition is achieved by Cdc2-
mediated phosphorylation of an NSF-associated factor at 
early mitosis. But how the cell cycle regulates the second, the 
p47/p97 pathway, was not known.
 Uchiyama et al. have determined 
that Cdc2-mediated phosphorylation 
also inhibits the p47/p97 pathway. 
p97 is an ATPase that binds to the 
Golgi through its associated factor, 
p47. Uchiyama et al. find that p47 
is phosphorylated by Cdc2 upon 
entry into mitosis. Phosphorylated 
p47 bound to p97 in mitotic cells 
and had a decreased binding affinity 
for Golgi membranes, thus releasing 
the complex from the Golgi.
 Addition of a phosphorylation-
insensitive version of p47 to mitotic 
cells blocked Golgi breakdown. 
However, the mutant did not impair 
proper separation of the Golgi into 
the daughter cells. How the Golgi 
can partition without first disassem-
bling in mammalian cells is unclear. 
Perhaps they are able to undergo fission, as in 
 
Toxoplasma
 
. 
Additionally, we are left to ponder why Golgi disassembly 
is essential for entry into mitosis, and indeed why Golgi 
complexes disassemble at all. 
 
 
G
Blocking p47 phosphory-
lation (below) prevents 
Golgi (green) disassembly.
 
E-cadherin immobilizes cells from the inside
 
s invasive cells, metastatic tumor cells 
must be free-roaming—able to detach 
from the extracellular matrix and neighboring 
cells. So when E-cadherin, a cell–cell 
adhesion molecule, was found to suppress 
invasion, it was logical to attribute this ability 
to its adhesive properties. But results by 
Wong and Gumbiner on page 1191 
indicate that E-cadherin uses an adhesion-
independent mechanism to inhibit the 
invasiveness of human cancer cells.
The authors studied the effects of various 
E-cadherin constructs on two invasive cell 
lines derived from breast and prostate cancers. 
They found that intracellular signaling, not 
adhesion, mediated E-cadherin’s tumor 
A
 
suppressor function. The adhesive portion 
of E-cadherin, its extracellular domain, was 
neither necessary nor sufficient to stop 
invasive behavior. In contrast, constructs 
containing E-cadherin’s cytoplasmic tail, 
in particular the 
 
 
 
-catenin–interacting 
domain, inhibited the invasive phenotype 
of the cells.
 
 
 
-Catenin, as part of the Wnt signaling 
pathway, activates transcription of a set 
of target genes that induce cell motility, 
including a matrix metalloproteinase. 
E-cadherin can suppress 
 
 
 
-catenin action 
by sequestering the protein from its target 
genes, and indeed the authors found that 
loss of 
 
 
 
-catenin also stopped invasion. 
However, invasion inhibition did not 
depend on transcription of known targets 
of TCF transcription factors, which are 
known to associate with 
 
 
 
-catenin. This 
conundrum leaves the authors in search 
of another 
 
 
 
-catenin target, perhaps 
another transcription factor, that regulates 
invasiveness.
 
 
 
 
E-cadherin stops invasion by making cells 
sticky (left), but not if its intracellular 
domain is missing (right).
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